Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 6
Submit an article Journal homepage
1,052
Views
25
CrossRef citations to date
0
Altmetric
Brief Report

Tocilizumab in patients with multisystem Erdheim–Chester disease

Alvise BertiUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy;Vita-Salute San Raffaele University, Milan, Italy
,
Giulio CavalliUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy;Vita-Salute San Raffaele University, Milan, Italy
,
Barbara GuglielmiUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
,
Riccardo BiavascoVita-Salute San Raffaele University, Milan, Italy
,
Corrado CampochiaroUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy;Vita-Salute San Raffaele University, Milan, Italy
,
Alessandro TomelleriUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy;Vita-Salute San Raffaele University, Milan, Italy
,
Roberto NicolettiDepartment of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy
,
Andrea PanzacchiDepartment of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
,
Marina FerrariniDivision of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
&
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy;Vita-Salute San Raffaele University, Milan, ItalyCorrespondence[email protected]
 show all
Article: e1318237 | Received 15 Feb 2017, Accepted 07 Apr 2017, Published online: 30 May 2017

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ji Kwan Park, Laura C. Huang & Andrea L. Kossler. (2023) Erdheim–Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes. Orbit 42:3, pages 233-244.
Read now
Giulio Cavalli & Ennio Giulio Favalli. (2019) Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis. Expert Review of Clinical Immunology 15:12, pages 1313-1322.
Read now
Fréderic Franconieri, Samuel Deshayes, Hubert de Boysson, Salim Trad, Nicolas Martin Silva, Benjamin Terrier, Boris Bienvenu, Françoise Galateau-Sallé, Jean-François Emile, Alison C. Johnson & Achille Aouba. (2018) Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment. OncoImmunology 7:8.
Read now

Articles from other publishers (22)

Yongchang Liu, Changpin Huang, Xiaohu Meng, Xin Fang, Xupin Xie, Changrong Wang & Meiyun Wang. (2022) Rare presentation of multiple thromboses in Erdheim–Chester disease: a case-based review. International Journal of Hematology 116:5, pages 798-806.
Crossref
Andrew G. Nicholson, Aliya N. Husain & Alain C. Borczuk. 2022. Tumors of the Serosal Membranes. Tumors of the Serosal Membranes 133 142 .
Jiangping He, Xin Fang, Xianfeng Zhang, Kuang Chen & Jiao Huang. (2022) Extensive Aortic Thromboembolism in a Patient With Erdheim-Chester Disease: A Case Report. Frontiers in Cardiovascular Medicine 9.
Crossref
Yimei Ma, Xia Guo, Zhi Wan, Hanmin Liu & Ju Gao. (2022) Paediatric Erdheim-Chester Disease in the Lateral Ventricle: A Case Report and Review of the Literature. Frontiers in Oncology 12.
Crossref
Ran Weissman, Eli L. Diamond, Julien Haroche, Benjamin H. Durham, Fleur Cohen, Justin Buthorn, Zahir Amoura, Jean-François Emile, Roei D. Mazor, Noam Shomron, Omar I. Abdel-Wahab, Ofer Shpilberg & Oshrat Hershkovitz-Rokah. (2021) MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis. Leukemia 36:4, pages 1139-1149.
Crossref
Raffaella MolteniRiccardo BiavascoDavide Stefanoni, Travis NemkovJorge Domínguez-Andrés, Rob J. Arts, Ivan Merelli, Davide Mazza, Samuel ZambranoMaddalena PanigadaEleonora CantoniIsak W. Tengesdal, Philippe MaksudFrancesco PirasDaniela CesanaLaura CassinaGianfranco DistefanoAlessia Loffreda, Daniela Gnani, Giacomo De LucaAlessandro Tomelleri, Corrado Campochiaro, Leo A. B. Joosten, Charles A. DinarelloAnna Kajaste-Rudnitski, Julien HarocheSimone CardaciSimone Cenci, Lorenzo Dagna, Claudio Doglioni, Marina Ferrarini, Elisabetta Ferrero, Alessandra BolettaAngelo D’Alessandro, Eugenio MontiniMihai G. Netea & Giulio Cavalli. (2021) Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood 138:17, pages 1554-1569.
Crossref
Jean-François Emile, Fleur Cohen-Aubart, Matthew Collin, Sylvie Fraitag, Ahmed Idbaih, Omar Abdel-Wahab, Barrett J Rollins, Jean Donadieu & Julien Haroche. (2021) Histiocytosis. The Lancet 398:10295, pages 157-170.
Crossref
Rajesh Rajavelu, AjoyP Shetty, RishiM Kanna & S Rajasekaran. (2021) Myelopathy secondary to isolated thoracic spine involvement mimicking metastasis in Erdheim–Chester disease: A case report and review of literature. Indian Spine Journal 4:1, pages 133.
Crossref
Marie-Lise Jaffrain-Rea & Silvia Filipponi. 2021. Polyendocrine Disorders and Endocrine Neoplastic Syndromes. Polyendocrine Disorders and Endocrine Neoplastic Syndromes 143 169 .
Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri & Lorenzo Dagna. (2020) Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic. Frontiers in Pharmacology 11.
Crossref
Francesco Pegoraro, Matthias Papo, Valerio Maniscalco, Frédéric Charlotte, Julien Haroche & Augusto Vaglio. (2020) Erdheim–Chester disease: a rapidly evolving disease model. Leukemia 34:11, pages 2840-2857.
Crossref
Oleg Iaremenko, Liubov Petelytska, Olena Dyadyk, Nataliia Negria & Dmytro Fedkov. (2020) Clinical presentation, imaging and response to interferon-alpha therapy in Erdheim–Chester disease: case-based review. Rheumatology International 40:9, pages 1529-1536.
Crossref
Johnny Chahine, Jafar Alzubi, Hanan Alnajjar, Jay Ramchand, Michael Chetrit & Allan L. Klein. (2020) Erdheim-Chester Disease: a Rare but Important Cause of Recurrent Pericarditis. Current Cardiology Reports 22:8.
Crossref
Giulio Cavalli, Lorenzo Dagna, Riccardo Biavasco, Antonello Villa, Claudio Doglioni, Elisabetta Ferrero & Marina Ferrarini. (2020) Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer. Journal of Leukocyte Biology 108:2, pages 591-599.
Crossref
Gaurav Goyal, Mark L. HeaneyMatthew Collin, Fleur Cohen-Aubart, Augusto VaglioBenjamin H. Durham, Oshrat Hershkovitz-RokahMichael GirschikofskyEric D. JacobsenKazuhiro ToyamaAaron M. GoodmanPaul Hendrie, Xin-xin Cao, Juvianee I. Estrada-Veras, Ofer ShpilbergAndré Abdo, Mineo KurokawaLorenzo Dagna, Kenneth L. McClain, Roei D. Mazor, Jennifer PicarsicFilip JankuRonald S. GoJulien Haroche & Eli L. Diamond. (2020) Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135:22, pages 1929-1945.
Crossref
Xin-xin Cao, Na Niu, Jian Sun, Hao Cai, Feng-dan Wang, Yi-ning Wang, Ming-hui Duan, Dao-bin Zhou & Jian Li. (2019) Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease. Orphanet Journal of Rare Diseases 14:1.
Crossref
Matthias Papo, Jean-François Emile, Thiago Trovati Maciel, Pierre Bay, Alistair Baber, Olivier Hermine, Zahir Amoura & Julien Haroche. (2019) Erdheim-Chester Disease: a Concise Review. Current Rheumatology Reports 21:12.
Crossref
Matthias Papo, Fleur Cohen-Aubart, Ludovic Trefond, Adeline Bauvois, Zahir Amoura, Jean-François Emile & Julien Haroche. (2019) Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders. Current Oncology Reports 21:7.
Crossref
Marie-Lise Jaffrain-Rea & Silvia Filipponi. 2019. Polyendocrine Disorders and Endocrine Neoplastic Syndromes. Polyendocrine Disorders and Endocrine Neoplastic Syndromes 1 27 .
Giulio Cavalli & Charles A. Dinarello. (2018) Anakinra Therapy for Non-cancer Inflammatory Diseases. Frontiers in Pharmacology 9.
Crossref
Alessandro Tomelleri, Giulio Cavalli, Giacomo De Luca, Corrado Campochiaro, Teresa D’Aliberti, Moreno Tresoldi & Lorenzo Dagna. (2018) Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease. Frontiers in Immunology 9.
Crossref
Christoph Garbers, Sylvia Heink, Thomas Korn & Stefan Rose-John. (2018) Interleukin-6: designing specific therapeutics for a complex cytokine. Nature Reviews Drug Discovery 17:6, pages 395-412.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.